Assessment of prognosis for racing after carpal surgery in 210 Thoroughbreds.

The study examines the effectiveness of carpal surgery on Thoroughbred racehorses and its impact on their performance and earnings, by comparing to a control group. It finds that the treated horses participate in and win fewer races but their earnings aren’t significantly affected, while arthritis, fracture location and a displaced chip do not influence performance in horses with a single-site chip lesion.

Research Topic and Methodology

• The focus of this study is to assess the outcome of carpal surgery in Thoroughbred racehorses.
• The researchers evaluated the efficiency of treating carpal lesions by arthrotomy in 210 Thoroughbred racehorses.
• Survival analysis was used to compare performances and earnings of these treated horses with those of 840 control horses that didn’t have the surgery.

Key Findings

• It was found that the horses which had undergone surgery were significantly inferior in regards to the number of races they contested, as well as the number of races won and places achieved.
• Despite their hindered performance, there was no significant difference concerning earnings; the treated horses didn’t earn less than the control group.
• The researchers also found that the presence of arthritis, the location of the bone fracture, and the presence of a displaced chip did not play a role in affecting the racing performance of horses which had a single-site lesion involving a chip.

Interpretation and Implications

• Overall, the study suggests that while carpal surgery may affect a Thoroughbred’s racing performance in terms of participation and wins, it doesn’t significantly impact their earnings.
• This might be due to the higher profitability of few high stake races as opposed to many low-stake races.
• Furthermore, for horses suffering from a single-site chip lesion, commonly found problems like arthritis, fracture site, and a displaced chip are not factors negatively impacting their performance after surgery.